Molecular Devices

Select high-value cell lines like a pro

During the last decade, production of monoclonal antibodies (mAbs) and recombinant proteins using mammalian cells have led to a boom in the introduction of biotherapeutic proteins to the market. As growth continues, the need to reduce cell line development costs and shorten the time to market is more critical than ever. In this eBook, we present an overview of the cell line development workflow as well as high-throughput solutions for accelerating the process, thus enabling quicker and easier selection of high-value cell lines. 

Topics include:

  • Cell line development workflow
  • Comparison of clone screening technologies
  • Monoclonality
  • A case study on improving mAb cell line production yield
  • Hybridoma selection using HAT

Please fill out the form to download the eBook. 

By submitting your details, you confirm that you have reviewed and agree with the Molecular Devices Privacy Policy, and that you understand your privacy choices as they pertain to your personal data as provided in the Privacy Policy under “Your Privacy Choices”.